The Hepatitis B Prescriber Forum is a half-day forum designed for hepatitis B s100 prescribers that will cover current and relevant sector priorities and topics.
With expert panels and interactive case discussions, the 2026 Hepatitis B Prescriber Forum is an opportunity to dive deep into emerging areas of hepatitis B treatment and management and discuss the contemporary issues facing hepatitis B clinical care in Australia.
Submit and Present a Case Study at the forum
Attendees are also encouraged to submit a 10-minute case study for presentation at the 2026 Hepatitis B Prescriber Forum.
By submitting and discussing a case, you can receive an additional HBV CPD point, totalling 3 CPD points to acquire all required CPD points for the year.
CLICK HERE: To submit your Case Study by Friday 27 February 2026.
Date, Time & Platform:
Platform: Online – Zoom
Date: Friday, 27 March 2026
Time:
- 12:00 PM – 4:30 PM (AEDT)
- 11:30AM – 4:00PM (ACDT)
- 11:00AM – 3:30PM (AEST)
- 10:30AM – 3:00PM (ACST)
- 9:00AM – 1:30PM (AWST)
Learning Outcomes:
On completion of this course and its components, participants will be able to:
- Describe barriers to accessing hepatitis B management, treatment, and linkage to care
- Evaluate hepatitis B patients’ suitability for monitoring and treatment
- Develop guideline-based approaches for managing patients with hepatitis B, referring to both clinical- and community-facing resources
Recommended Resources:
- Decision Making In Hepatitis B | ASHM Health
- Viral Hepatitis Mapping Project: National Reports | ASHM Health
- ASHM Testing Portal | ASHM Health
- B Positive: Hepatitis B Guide for Primary Care | ASHM Health
Funding:
This course received funding from the Australian Government Department of Health, Disability and Ageing.
CPD & Endorsement:
HBV s100 prescribers will receive 2 HBV CPD points for attending the Hepatitis B Prescriber Forum.
By submitting and discussing your model of care, you can receive an additional HBV CPD point, totalling 3 CPD points to acquire all required CPD points for the year.
RACGP
This course has been approved as a CPD activity by RACGP for the 2026-2028 triennium. Educational Activities: 4 hours. RACGP Activity Number: 397119
ACCRM
This course has been approved by ACRRM as an accredited activity. Allocated total 4 PDP units: 4 Educational Activity.
ACNP
This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for 4 CPD hours. Endorsed until 14/1/2027.
Target Audience:
Hepatitis B s100 GP and NP Prescribers, Sexual Health Registrars and Physicians, Infectious Diseases Trainees and Physicians, and medical practitioners who are interested in prescribing Hepatitis B s100 medication and managing patients living with hepatitis B.
